Replies to post #2839 on Galectin Therapeutics Inc. (GALT)

[Chess Master]

Look you guys can be bitter all you want about the screw-ups but heres the bottom line. Does it matter where the publicity is coming from? This stock is undervalued PERIOD. If they hit their end points is a mult billion dollar company. No one disagrees. Well what is the probability of that. Lets say 1 in 10. Theres 10% chance of approval for NASH. Well the stock today should be worth about $200 mill or about $6 per share. Based on those crazy warrant trading its not hard to see the tea leaves on this one.

Article mentions GALT as a technology platform
http://seekingalpha.com/article/4045570-funding-problems-encompass-seattle-genetics-immunomedics-deal